Clinic
Windrose Health Network, INC.
Windrose Health Network, INC. was paid $6.04M by Medicaid between Jan 2018 and Dec 2024, across 98 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoWINDROSE HEALTH NETWORK, INC.
INDIANAPOLIS, IN 46227
INDIANAPOLIS, IN 46227
33aNPI1881061059assigned 08/24/2015
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$6.04M
24GClaims197,234
24DCodes billed98
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in Indiana
Rank by total paid#14 of 156
Median peer was paid$568K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,220 | $402K | |
| 2019 | 9,226 | $555K | |
| 2020 | 10,189 | $606K | |
| 2021 | 34,250 | $990K | |
| 2022 | 46,199 | $1.10M | |
| 2023 | 44,652 | $1.30M | |
| 2024incomplete | 40,498 | $1.09M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 29,177 | 24,611 | $1.65M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 13,993 | 11,994 | $1.07M |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 14% | 54,025 | 41,161 | $822K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.8% | 4,886 | 4,590 | $408K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.1% | 4,472 | 4,214 | $368K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.1% | 3,968 | 3,589 | $310K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.9% | 2,216 | 2,015 | $175K |
| 59425 | 2.4% | 2,616 | 2,057 | $143K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.4% | 13,049 | 10,980 | $142K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 2.3% | 1,525 | 1,359 | $136K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 2.2% | 2,357 | 1,234 | $135K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.0% | 3,459 | 3,050 | $122K |
86 more codes
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.9% | 1,333 | $114K |
| 90837 | Psychotherapy session, about an hour | 1.4% | 1,178 | $85K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.2% | 4,521 | $75K |
| 59426 | <1% | 1,192 | $48K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,091 | $34K |
| 90686 | <1% | 8,263 | $23K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,089 | $19K |
| 92551 | <1% | 2,520 | $19K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 229 | $16K |
| 99385 | <1% | 168 | $15K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 111 | $14K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,976 | $14K |
| 0072A | <1% | 364 | $12K | |
| 36416 | <1% | 3,149 | $9K | |
| 0071A | <1% | 204 | $7K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 191 | $4K |
| 90715 | <1% | 255 | $4K | |
| 99173 | <1% | 2,679 | $4K | |
| 99383 | <1% | 42 | $4K | |
| 99000 | <1% | 1,107 | $3K | |
| 83655 | <1% | 434 | $3K | |
| 99386 | <1% | 25 | $3K | |
| 90474 | <1% | 195 | $3K | |
| 0004A | <1% | 125 | $3K | |
| 99177 | <1% | 827 | $3K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 32 | $2K |
| 99381 | <1% | 43 | $2K | |
| 99382 | <1% | 24 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 237 | $2K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 12 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 211 | $1K |
| G0467 | Community health center visit, returning patient | <1% | 90 | $1K |
| 85018 | <1% | 771 | $1K | |
| 81003 | <1% | 338 | $509.42 | |
| 0001A | <1% | 19 | $483.73 | |
| 0052A | <1% | 33 | $442.80 | |
| 0154A | <1% | 36 | $442.80 | |
| 3044F | <1% | 68 | $440.00 | |
| 96380 | <1% | 46 | $405.00 | |
| 0064A | <1% | 22 | $372.10 | |
| 0054A | <1% | 42 | $369.00 | |
| 82948 | <1% | 224 | $355.64 | |
| 90651 | <1% | 772 | $273.45 | |
| 87400 | <1% | 81 | $251.18 | |
| 81025 | <1% | 47 | $244.84 | |
| 59430 | <1% | 36 | $175.00 | |
| 90656 | <1% | 765 | $174.63 | |
| 80061 | Lipid panel | <1% | 13 | $174.07 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 13 | $119.76 |
| 96127 | <1% | 11,395 | $47.76 | |
| 90688 | <1% | 69 | $15.77 | |
| 96160 | 0% | 493 | $0.00 | |
| 90671 | 0% | 354 | $0.00 | |
| 3078F | 0% | 1,609 | $0.00 | |
| 3077F | 0% | 201 | $0.00 | |
| 90670 | 0% | 451 | $0.00 | |
| 90633 | 0% | 224 | $0.00 | |
| 91300 | 0% | 162 | $0.00 | |
| 90681 | 0% | 71 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 25 | $0.00 |
| 90734 | 0% | 37 | $0.00 | |
| 99354 | 0% | 20 | $0.00 | |
| 91321 | 0% | 16 | $0.00 | |
| 90685 | 0% | 21 | $0.00 | |
| 90710 | 0% | 85 | $0.00 | |
| 90619 | 0% | 222 | $0.00 | |
| 90697 | 0% | 187 | $0.00 | |
| 3074F | 0% | 3,754 | $0.00 | |
| 90680 | 0% | 299 | $0.00 | |
| 91307 | 0% | 429 | $0.00 | |
| 3080F | 0% | 402 | $0.00 | |
| 96161 | 0% | 406 | $0.00 | |
| 3075F | 0% | 354 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 182 | $0.00 |
| 90723 | 0% | 65 | $0.00 | |
| 90696 | 0% | 68 | $0.00 | |
| 90744 | 0% | 46 | $0.00 | |
| 87428 | 0% | 79 | $0.00 | |
| 90677 | 0% | 253 | $0.00 | |
| 91305 | 0% | 46 | $0.00 | |
| 90698 | 0% | 128 | $0.00 | |
| 90647 | 0% | 26 | $0.00 | |
| G9226 | Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) | 0% | 14 | $0.00 |
| 90480 | 0% | 29 | $0.00 | |
| 90620 | 0% | 14 | $0.00 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROLLETT, SCOTT (CEO)
Parent organizationWINDROSE HEALTH NETWORK, INC.
| Provider | Location | Paid |
|---|---|---|
| Windrose Health Network, INC. | Indianapolis, IN | $4.41M |
| Windrose Health Network, INC. | Franklin, IN | $4.37M |
| Windrose Health Network, INC. | Trafalgar, IN | $2.99M |
| Windrose Health Network, INC. | Hope, IN | $2.21M |
| Windrose Health Network, INC. | Whiteland, IN | $738K |
| Windrose Health Network, INC. | Edinburgh, IN | $14K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.